Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://link.springer.com/article/10.1245/s10434-008-0134-5, but it redirected us to https://link.springer.com/article/10.1245/s10434-008-0134-5. The analysis below is for the second page.

Title[redir]:
Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma | Annals of Surgical Oncology
Description:
Staging laparoscopy for patients with radiographically resectable pancreatic adenocarcinoma has been reported to yield an 8–15% finding of unresectable disease. Factors associated with the likelihood of subradiographic unresectable disease have not been clearly defined. A prospectively maintained pancreatic database was reviewed and patients were identified who underwent staging laparoscopy for radiographically resectable pancreatic adenocarcinoma between January 2000 and December 2006. Preoperative carbohydrate antigen 19-9 (CA 19-9) values were assessed for their association with the presence of subradiographic unresectable disease. Four hundred ninety-one patients underwent staging laparoscopy. Resection was performed in 80% (n = 395). Of the 96 patients with unresectable disease, 75 (78%) had metastases either in the liver (n = 60) or peritoneum (n = 15). Preoperative CA 19-9 values were available for 262 of the 491 patients. Fifty-one of these patients had unresectable disease, of which 78% were due to distant disease. The median preoperative CA 19-9 value for patients who underwent resection was 131 U/ml versus 379 U/ml for those patients with unresectable disease (P = 0.003). A receiver operating characteristics (ROC) curve was developed for preoperative CA 19-9 value and tumor resectability. The statistically optimal cutoff value was determined to be 130 U/ml. Unresectable disease was identified in 38 of the 144 patients (26.4%) with a preoperative CA 19-9 ā‰„ 130 U/ml, and in 13 of the 118 patients (11%) with a CA 19-9 < 130 U/ml (P = 0.003). CA 19-9 values greater than 130 U/ml remained a predictor of tumor unresectability on multivariate regression analysis [hazard ratio (HR) 2.70, 95% confidence interval (CI) 1.34–5.44; P = 0.005]. In this study, preoperative CA 19-9 values were strongly associated with the identification of subradiographic unresectable disease. Preoperative CA 19-9 values may allow surgeons to better select patients for staging laparoscopy.

Matching Content Categories {šŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {šŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {šŸ’ø}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {šŸ”}

article, pancreatic, google, scholar, pubmed, staging, surg, patients, laparoscopy, cas, cancer, preoperative, resectability, adenocarcinoma, unresectable, disease, resectable, uml, access, privacy, cookies, content, values, tumor, helical, malignancy, levels, gastrointest, serum, publish, search, radiographically, winston, survival, carcinoma, oncol, ann, york, usa, data, information, log, journal, research, yield, maithel, maloney, brennan, peter, allen,

Topics {āœ’ļø}

month download article/chapter receiver operating characteristics dual-phase helical ct unresectable intra-abdominal malignancies tumor unresectability resectable pancreatic cancer full article pdf subradiographic unresectable disease privacy choices/manage cookies resectable pancreatic adenocarcinoma surgical oncology aims minimal access surgery mithat gönen phd pancreatic cancer resectability pancreatic ductal adenocarcinoma changing prognosis spiral computed tomography logistic regression models helical computed tomography potentially resectable carcinoma pancreatic tumors published underwent staging laparoscopy undetectable preoperative levels corrine winston md european economic area statistically optimal cutoff magnetic resonance imaging nonspecific gastrointestinal symptoms suspected pancreatic malignancy article annals conditions privacy policy pancreatic cancer chin med sci unresectable disease tumor resectability assessment accepting optional cookies stephen maloney md curve check access improved survival instant access brennan md & peter article log pancreatic adenocarcinoma journal finder publish author correspondence time article 21 article maithel chin ac tumor markers

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma
         description:Staging laparoscopy for patients with radiographically resectable pancreatic adenocarcinoma has been reported to yield an 8–15% finding of unresectable disease. Factors associated with the likelihood of subradiographic unresectable disease have not been clearly defined. A prospectively maintained pancreatic database was reviewed and patients were identified who underwent staging laparoscopy for radiographically resectable pancreatic adenocarcinoma between January 2000 and December 2006. Preoperative carbohydrate antigen 19-9 (CA 19-9) values were assessed for their association with the presence of subradiographic unresectable disease. Four hundred ninety-one patients underwent staging laparoscopy. Resection was performed in 80% (nĀ =Ā 395). Of the 96 patients with unresectable disease, 75 (78%) had metastases either in the liver (nĀ =Ā 60) or peritoneum (nĀ =Ā 15). Preoperative CA 19-9 values were available for 262 of the 491 patients. Fifty-one of these patients had unresectable disease, of which 78% were due to distant disease. The median preoperative CA 19-9 value for patients who underwent resection was 131Ā U/ml versus 379Ā U/ml for those patients with unresectable disease (PĀ =Ā 0.003). A receiver operating characteristics (ROC) curve was developed for preoperative CA 19-9 value and tumor resectability. The statistically optimal cutoff value was determined to be 130Ā U/ml. Unresectable disease was identified in 38 of the 144 patients (26.4%) with a preoperative CA 19-9 ≄ 130Ā U/ml, and in 13 of the 118 patients (11%) with a CA 19-9Ā <Ā 130Ā U/ml (PĀ =Ā 0.003). CA 19-9 values greater than 130Ā U/ml remained a predictor of tumor unresectability on multivariate regression analysis [hazard ratio (HR) 2.70, 95% confidence interval (CI) 1.34–5.44; PĀ =Ā 0.005]. In this study, preoperative CA 19-9 values were strongly associated with the identification of subradiographic unresectable disease. Preoperative CA 19-9 values may allow surgeons to better select patients for staging laparoscopy.
         datePublished:2008-09-10T00:00:00Z
         dateModified:2008-09-10T00:00:00Z
         pageStart:3512
         pageEnd:3520
         sameAs:https://doi.org/10.1245/s10434-008-0134-5
         keywords:
            Pancreatic Adenocarcinoma
            Receiver Operating Characteristic Curve
            Unresectable Disease
            Staging Laparoscopy
            Tumor Unresectability
            Surgical Oncology
            Oncology
            Surgery
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-008-0134-5/MediaObjects/10434_2008_134_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-008-0134-5/MediaObjects/10434_2008_134_Fig2_HTML.gif
         isPartOf:
            name:Annals of Surgical Oncology
            issn:
               1534-4681
               1068-9265
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shishir K. Maithel
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephen Maloney
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Corrine Winston
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Radiology, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mithat Gƶnen
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Epidemiology and Biostatistics, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael I. D’Angelica
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ronald P. DeMatteo
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:William R. Jarnagin
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Murray F. Brennan
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter J. Allen
               affiliation:
                     name:Memorial Sloan–Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma
      description:Staging laparoscopy for patients with radiographically resectable pancreatic adenocarcinoma has been reported to yield an 8–15% finding of unresectable disease. Factors associated with the likelihood of subradiographic unresectable disease have not been clearly defined. A prospectively maintained pancreatic database was reviewed and patients were identified who underwent staging laparoscopy for radiographically resectable pancreatic adenocarcinoma between January 2000 and December 2006. Preoperative carbohydrate antigen 19-9 (CA 19-9) values were assessed for their association with the presence of subradiographic unresectable disease. Four hundred ninety-one patients underwent staging laparoscopy. Resection was performed in 80% (nĀ =Ā 395). Of the 96 patients with unresectable disease, 75 (78%) had metastases either in the liver (nĀ =Ā 60) or peritoneum (nĀ =Ā 15). Preoperative CA 19-9 values were available for 262 of the 491 patients. Fifty-one of these patients had unresectable disease, of which 78% were due to distant disease. The median preoperative CA 19-9 value for patients who underwent resection was 131Ā U/ml versus 379Ā U/ml for those patients with unresectable disease (PĀ =Ā 0.003). A receiver operating characteristics (ROC) curve was developed for preoperative CA 19-9 value and tumor resectability. The statistically optimal cutoff value was determined to be 130Ā U/ml. Unresectable disease was identified in 38 of the 144 patients (26.4%) with a preoperative CA 19-9 ≄ 130Ā U/ml, and in 13 of the 118 patients (11%) with a CA 19-9Ā <Ā 130Ā U/ml (PĀ =Ā 0.003). CA 19-9 values greater than 130Ā U/ml remained a predictor of tumor unresectability on multivariate regression analysis [hazard ratio (HR) 2.70, 95% confidence interval (CI) 1.34–5.44; PĀ =Ā 0.005]. In this study, preoperative CA 19-9 values were strongly associated with the identification of subradiographic unresectable disease. Preoperative CA 19-9 values may allow surgeons to better select patients for staging laparoscopy.
      datePublished:2008-09-10T00:00:00Z
      dateModified:2008-09-10T00:00:00Z
      pageStart:3512
      pageEnd:3520
      sameAs:https://doi.org/10.1245/s10434-008-0134-5
      keywords:
         Pancreatic Adenocarcinoma
         Receiver Operating Characteristic Curve
         Unresectable Disease
         Staging Laparoscopy
         Tumor Unresectability
         Surgical Oncology
         Oncology
         Surgery
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-008-0134-5/MediaObjects/10434_2008_134_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1245%2Fs10434-008-0134-5/MediaObjects/10434_2008_134_Fig2_HTML.gif
      isPartOf:
         name:Annals of Surgical Oncology
         issn:
            1534-4681
            1068-9265
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shishir K. Maithel
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephen Maloney
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Corrine Winston
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Radiology, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mithat Gƶnen
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Epidemiology and Biostatistics, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael I. D’Angelica
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ronald P. DeMatteo
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:William R. Jarnagin
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Murray F. Brennan
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter J. Allen
            affiliation:
                  name:Memorial Sloan–Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Annals of Surgical Oncology
      issn:
         1534-4681
         1068-9265
      volumeNumber:15
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Radiology, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Epidemiology and Biostatistics, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan–Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shishir K. Maithel
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:Stephen Maloney
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:Corrine Winston
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Radiology, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:Mithat Gƶnen
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Epidemiology and Biostatistics, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:Michael I. D’Angelica
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:Ronald P. DeMatteo
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:William R. Jarnagin
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:Murray F. Brennan
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:Peter J. Allen
      affiliation:
            name:Memorial Sloan–Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
      name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
      name:Department of Radiology, Memorial Sloan–Kettering Cancer Center, New York, USA
      name:Department of Epidemiology and Biostatistics, Memorial Sloan–Kettering Cancer Center, New York, USA
      name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
      name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
      name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
      name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
      name:Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {šŸ”—}(177)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

Emails and Hosting {āœ‰ļø}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {šŸ“¦}

  • Crossref

5.14s.